Target intelligence / Profile preview

LRIG3 divergent transcript (LRIG3-DT)

Target: LRIG3-DT
Molecular classification: Other

Overview

LRIG3-DT (LRIG3 divergent transcript) is an annotated non-coding RNA whose locus diverges from the LRIG3 gene region. It does not code for a protein and is not recognized as an enzyme, receptor, transporter, or therapeutic target. Most research and biological characterization have focused on the main LRIG3 gene, which encodes a single-pass transmembrane protein involved in neural crest formation and modulation of key signaling cascades (such as FGF, Wnt, and BMP) during embryonic development[1][2][3][5][4]. The divergent transcript itself does not have established molecular function, disease association, or role in drug interactions.

Other names: LRIG3-DT

Beyond the preview

Go deeper on LRIG3 divergent transcript (LRIG3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LRIG3 divergent transcript (LRIG3-DT).

Explore the full profile